Irmarie Rivera-Reyes
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Investigational Use of Real-World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/II MORPHEUS Trial.
Journal: Clinical pharmacology and therapeutics
Published: June 19, 2024
Pertuzumab Plus Trastuzumab for Treatment-Refractory HER2-Amplified Metastatic Colorectal Cancer: Comparison of the MyPathway Trial With a Real-World External Control Arm.
Journal: JCO clinical cancer informatics
Published: June 01, 2022
Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice.
Journal: JCO clinical cancer informatics
Published: March 17, 2022
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer.
Journal: Communications medicine
Published: August 12, 2021
Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Journal: The Lancet. Oncology
Published: July 09, 2021
Building External Control Arms From Patient-Level Electronic Health Record Data to Replicate the Randomized IMblaze370 Control Arm in Metastatic Colorectal Cancer.
Journal: JCO clinical cancer informatics
Published: April 23, 2021
Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States.
Journal: Neuro-oncology practice
Published: August 07, 2019
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 16, 2013
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: November 22, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026